Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesShares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Regen BioPharma (RGBP) Short-Term Debt repayments (2016 - 2023)

Historic Short-Term Debt repayments for Regen BioPharma (RGBP) over the last 9 years, with Q1 2023 value amounting to $100000.0.

  • Regen BioPharma's Short-Term Debt repayments changed N/A to $100000.0 in Q1 2023 from the same period last year, while for Jun 2023 it was $100000.0, marking a year-over-year change of. This contributed to the annual value of $499.0 for FY2022, which is 9996.34% down from last year.
  • Latest data reveals that Regen BioPharma reported Short-Term Debt repayments of $100000.0 as of Q1 2023.
  • In the past 5 years, Regen BioPharma's Short-Term Debt repayments registered a high of $1.4 million during Q3 2021, and its lowest value of -$47900.0 during Q2 2021.
  • Its 4-year average for Short-Term Debt repayments is $190625.0, with a median of $17193.5 in 2019.
  • In the last 5 years, Regen BioPharma's Short-Term Debt repayments soared by 96290.0% in 2019 and then plummeted by 3764.71% in 2020.
  • Over the past 4 years, Regen BioPharma's Short-Term Debt repayments (Quarter) stood at -$31800.0 in 2019, then soared by 116.67% to $5300.0 in 2020, then skyrocketed by 26522.64% to $1.4 million in 2021, then plummeted by 92.91% to $100000.0 in 2023.
  • Its Short-Term Debt repayments stands at $100000.0 for Q1 2023, versus $1.4 million for Q3 2021 and -$47900.0 for Q2 2021.